AI Detects Breast Cancer

Mirai is an advanced artificial intelligence (AI) tool designed for breast cancer risk assessment, developed at the MIT Jameel Clinic by Regina Barzilay and her team.

The AI tool is currently in clinical trials at UMass Chan Medical School but is also being integrated globally, including with King Faisal Specialist Hospital in Saudi Arabia. It assesses risk by analyzing mammograms and factors like age and family history, showing high accuracy across diverse demographics. Mirai outperforms existing algorithms, identifying nearly twice as many future cancers while ensuring reliable predictions.

With innovative strategies and ongoing enhancements, Mirai is set to transform personalized cancer care and improve early detection rates.